These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6127352)

  • 41. Tardive dyskinesia.
    Jeste DV; Caligiuri MP
    Schizophr Bull; 1993; 19(2):303-15. PubMed ID: 8100643
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adolescents on neuroleptic medication: is this population at risk for tardive dyskinesia?
    McDermid SA; Hood J; Bockus S; D'Alessandro E
    Can J Psychiatry; 1998 Aug; 43(6):629-31. PubMed ID: 9729692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Persistent tardive dyskinesia: demographic and pharmacological risk factors.
    Muscettola G; Pampallona S; Barbato G; Casiello M; Bollini P
    Acta Psychiatr Scand; 1993 Jan; 87(1):29-36. PubMed ID: 8093821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of tardive dyskinesia in a clinic population.
    Fleischhauer J; Kocher R; Hobi V; Gilsdorf U
    Psychopharmacology Suppl; 1985; 2():162-72. PubMed ID: 2860658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tardive dyskinesia in schizophrenic outpatients.
    Kok LP; Christopher YS
    Ann Acad Med Singap; 1985 Jan; 14(1):87-90. PubMed ID: 2860841
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment.
    Byne W; White L; Parella M; Adams R; Harvey PD; Davis KL
    Int J Geriatr Psychiatry; 1998 Jul; 13(7):473-9. PubMed ID: 9695037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Awareness of tardive dyskinesia in Asian patients with schizophrenia.
    Chong SA; Remington G; Mahendran R; Chua HC
    J Clin Psychopharmacol; 2001 Apr; 21(2):235-7. PubMed ID: 11270922
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of tardive dyskinesia: results of a cross-sectional study in an outpatient population.
    Morgenstern H; Glazer WM; Gibowski LD; Holmberg S
    J Chronic Dis; 1987; 40(4):319-27. PubMed ID: 2881941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tardive dyskinesia: reversible and irreversible.
    Casey DE
    Psychopharmacology Suppl; 1985; 2():88-97. PubMed ID: 2860664
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroleptic-induced tardive dyskinesia among Arab psychotic patients.
    Osman A; Marghalani M; Turkistani IY; Al-Swaf M; Bin Sadiq B
    East Mediterr Health J; 2007; 13(3):625-32. PubMed ID: 17687836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tardive dyskinesia prevalence rates during a ten-year follow-up.
    Miller CH; Simioni I; Oberbauer H; Schwitzer J; Barnas C; Kulhanek F; Boissel KE; Meise U; Hinterhuber H; Fleischhacker WW
    J Nerv Ment Dis; 1995 Jun; 183(6):404-7. PubMed ID: 7798090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A long-term outcome study of tardive dyskinesia in patients on antipsychotic medication.
    Koshino Y; Wada Y; Isaki K; Kurata K
    Clin Neuropharmacol; 1991 Dec; 14(6):537-46. PubMed ID: 1685353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tardive dyskinesia in non-western countries: a review.
    Pandurangi AK; Aderibigbe YA
    Eur Arch Psychiatry Clin Neurosci; 1995; 246(1):47-52. PubMed ID: 8773218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tardive and spontaneous dyskinesia incidence in the general population.
    Merrill RM; Lyon JL; Matiaco PM
    BMC Psychiatry; 2013 May; 13():152. PubMed ID: 23714238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tardive dyskinesia in the treatment of schizophrenia: the findings of the Research on Asian Psychotropic Prescription Pattern (REAP) survey (2001 - 2009).
    Xiang YT; Wang CY; Si TM; Lee EH; He YL; Ungvari GS; Chiu HF; Yang SY; Chong MY; Tan CH; Kua EH; Fujii S; Sim K; Yong KH; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Shinfuku N
    Int J Clin Pharmacol Ther; 2011 Jun; 49(6):382-7. PubMed ID: 21612745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and risk factors for severe tardive dyskinesia in older patients.
    Caligiuri MP; Lacro JP; Rockwell E; McAdams LA; Jeste DV
    Br J Psychiatry; 1997 Aug; 171():148-53. PubMed ID: 9337951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mortality rates among patients with schizophrenia and tardive dyskinesia.
    Chong SA; Tay JA; Subramaniam M; Pek E; Machin D
    J Clin Psychopharmacol; 2009 Feb; 29(1):5-8. PubMed ID: 19142099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Early versus late onset psychosis and tardive dyskinesia.
    Yassa R; Nair V; Schwartz G
    Biol Psychiatry; 1986 Nov; 21(13):1291-7. PubMed ID: 2875744
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum neuroleptic concentrations and tardive dyskinesia.
    Jeste DV; Linnoila M; Wagner RL; Wyatt RJ
    Psychopharmacology (Berl); 1982; 76(4):377-80. PubMed ID: 6126895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Antipsychotic Dosage in Patients With Tardive Dyskinesia: A Case-Control Study Using the Claims Database of the Corporate Health Insurance Association.
    Gouda M; Abe M; Watanabe Y; Kato TA
    J Clin Psychopharmacol; 2024 Jul-Aug 01; 44(4):378-385. PubMed ID: 38829574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.